bacterin
-
Recon
Xtant Medical finishes 3-D printer development for orthopedics: 4 key notes
By Laura Dyrda Xtant Medical’s subsidiary Bacterin developed a three-dimensional printer that can prototype custom, resorbable bone grafts for reconstructive procedures. Here…
Read More » -
Xtant Medical receives FDA clearance for demineralized bone matrix putty: 4 observations
By Anuja Vaidya Xtant Medical’s wholly owned subsidiary Bacterin has received FDA 510(k) clearance of its OsteoSelect PLUS Demineralized Bone Matrix Putty.…
Read More » -
Biologics
Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical
Combines Bacterin’s strength in orthobiologics with X-spine’s expertise in hardware offering complementary product lines focused on orthopedic and spine surgical…
Read More » -
Hospitals
Bacterin Announces OsteoSponge(R) Patent
BELGRADE, Mont., April 6, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More » -
Biologics
Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications
BELGRADE, Mont., Oct. 29, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More » -
Biologics
Bacterin International Announces Sales Team Expansion
Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) — Bacterin announced today three senior…
Read More » -
Biologics
Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery
BELGRADE, Mont., Aug. 5, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone…
Read More » -
Biologics
Bacterin Announces the Appointment of Robert Di Silvio as President
BELGRADE, Mont., July 1, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More » -
Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
BELGRADE, Mont., Aug. 1, 2011 /PRNewswire via COMTEX/ — Bacterin International Holdings, Inc.BONE -3.78% , a leader in the development of…
Read More » -
Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex
BELGRADE, Mont., March 4, 2011 /PRNewswire via COMTEX/ — BELGRADE, Mont.,March 4, 2011 /PRNewswire/ — Bacterin International Holdings, Inc. (OTC Bulletin Board:…
Read More » -
Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge(R)SC
BELGRADE, Mont., Feb. 28, 2011 /PRNewswire via COMTEX/ — Bacterin International Holdings, Inc. (“Bacterin”) (OTC Bulletin Board: BIHI), a developer…
Read More » -
Bacterin International Secures Up To $9 Million of Potential $14 Million of Financing
BELGRADE, Mont., Nov. 22, 2010 /PRNewswire-FirstCall/ — Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) (“Bacterin”), a creator and developer of revolutionary bone…
Read More » -
Bacterin Closes Private Placement With Total Raise of $9.2 Million
BELGRADE, Mont., Aug. 5 /PRNewswire-FirstCall/ — Bacterin International Holdings, Inc. (“Bacterin” or the “Company”) (OTC Bulletin Board: BIHI), a developer of anti-infective coatings…
Read More » -
Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlane’s Network of Over 6,000 Medical Facilities
BELGRADE, Mont., June 16 /PRNewswire/ — Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to…
Read More »